FDA label f18f1137-4bdc-6155-e053-2995a90a688f

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
dde4ccf4-152d-441a-bad1-53975bab5987
SPL ID
f18f1137-4bdc-6155-e053-2995a90a688f
Version
4
Effective date
2023-01-05
Source export date
2026-11-13
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/48e89e7994339d0e23bed7c09f727a47746d1fbd440ad66960650182851cb8a9/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:59:02

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: Do not take this product if you have any of the following: • heart disease • diabetes • high blood pressure • thyroid disease • or di culty in urination due to the enlargement of the prostate gland When using this product: DO NOT EXCEED RECOMMENDED DOSAGE. Stop use and ask a doctor if: • nervousness, dizziness or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by high fever • redness or swelling occur Drug Interaction Precaution: Do not use this product if you are now taking prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains an MAOI consult a health professional before taking this product.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.